Literature DB >> 6447694

Inhibition of casein kinase II by heparin.

G M Hathaway, T H Lubben, J A Traugh.   

Abstract

Casein kinase II, a cyclic nucleotide-independent protein kinase from rabbit reticulocytes, was shown to be inhibited by heparin. Heparin specifically inhibited the enzyme and had no effect on other protein kinases, including casein kinase I, the type I and II cAMP-dependent protein kinases, protease-activated kinase I, and the hemin-controlled repressor. Heparan sulfate was found to be 40-fold less effective than heparin towards casein kinase II; other acid mucopolysaccharides had little or no effect on the enzymatic activity. Steady state studies revealed that heparin acted as a competitive inhibitor with respect to the substrate, casein. A value of 20 ng/ml or about 1.4 nM was obtained for the apparent Ki. The inhibition was not reversed by ATP and varying the ATP and heparin concentrations in the assay only altered the maximum velocity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6447694

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  Localization of individual subunits of protein kinase CK2 to the endoplasmic reticulum and to the Golgi apparatus.

Authors:  M Faust; M Jung; J Günther; R Zimmermann; M Montenarh
Journal:  Mol Cell Biochem       Date:  2001-11       Impact factor: 3.396

2.  RNA polymerase I holoenzyme-promoter complexes include an associated CK2-like protein kinase.

Authors:  J Saez-Vasquez; M Meissner; C S Pikaard
Journal:  Plant Mol Biol       Date:  2001-10       Impact factor: 4.076

3.  Heparin binds to Leishmania donovani promastigotes and inhibits protein phosphorylation.

Authors:  N K Mukhopadhyay; K Shome; A K Saha; J R Hassell; R H Glew
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

4.  DNA repair protein O6-alkylguanine-DNA alkyltransferase is phosphorylated by two distinct and novel protein kinases in human brain tumour cells.

Authors:  S R Mullapudi; F Ali-Osman; J Shou; K S Srivenugopal
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

5.  Effects of the oral administration of glycosaminoglycans on cellular abnormalities associated with idiopathic calcium oxalate nephrolithiasis.

Authors:  B Baggio; G Gambaro; G Marzaro; F Marchini; A Borsatti; G Crepaldi
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

6.  Phosphorylation of IkappaBalpha in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability.

Authors:  R Lin; P Beauparlant; C Makris; S Meloche; J Hiscott
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

7.  Activation of casein kinase II and inhibition of phosphatase and tensin homologue deleted on chromosome 10 phosphatase by nerve growth factor/p75NTR inhibit glycogen synthase kinase-3beta and stimulate axonal growth.

Authors:  María-Angeles Arevalo; Alfredo Rodríguez-Tébar
Journal:  Mol Biol Cell       Date:  2006-05-24       Impact factor: 4.138

8.  Pentosan polysulfate, a potent anti HIV and anti tumor agent, inhibits protein serine/threonine and tyrosine kinases.

Authors:  A K Srivastava; R P Sékaly; J L Chiasson
Journal:  Mol Cell Biochem       Date:  1993-03-24       Impact factor: 3.396

9.  Phosphorylation of maize eukaryotic translation initiation factor 5A (eIF5A) by casein kinase 2: identification of phosphorylated residue and influence on intracellular localization of eIF5A.

Authors:  Maja Łebska; Arkadiusz Ciesielski; Lidia Szymona; Luiza Godecka; Elzbieta Lewandowska-Gnatowska; Jadwiga Szczegielniak; Grazyna Muszynska
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

10.  Phosphorylation of serine 205 by the protein kinase CK2 persists on Pax3-FOXO1, but not Pax3, throughout early myogenic differentiation.

Authors:  Kevin N Dietz; Patrick J Miller; Andrew D Hollenbach
Journal:  Biochemistry       Date:  2009-12-15       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.